Related to Transcriptome Yields Two Subtypes of Multiple Sclerosis

• Elan Makes $20M Investment in Proteostasis as Part of Drug Discovery Partnership for Neurodegenerative Diseases
  
• Evotec and PsychoGenics Ally to Offer Integrated CNS Drug Discovery Solutions
  
• EU Approves Biogen Idec’s Avonex Intramuscular Autoinjector Product for MS
  
• Merck Serono Pays Affectis €2.4M Up Front in Deal for Neurodegenerative Disease
  
• DoD Pledges $4.6M to Establish Infection Genomics Center at UTSA
  
• Researchers Say Human Nasal Cavity Stem Cells Repair Brain Damage in Mice
  
• Servier Positions Itself to Take Over Full Rights to CNS Disease Drug in Development with Cortex
  
• Life Technologies and Fox Chase Partner to Develop Routine Service for Cancer Genome Analysis
  
• Merck Serono Gives Up on Getting Drug Candidate for Multiple Sclerosis Approved
  
• Digna and Flamel Partner on Drug Delivery Formulations for Multiple Candidates
  
• GlycoRegImmune Partners with RxMD to Progress NK T Cell-Targeting Drugs
  
• TCGA Researchers Complete Comprehensive Genomic and Epigenomic Analyses of Ovarian Cancer
  
• UCB and Harvard Establish Research Alliance to Develop Antibody Therapeutics
  
• Sanofi and Genzyme Report Positive Data from Pivotal Trial Comparing Alemtuzumab with Rebif in MS
  
• Ipsen Renews Salk Institute Partnership and Signs Cancer Research Collaboration with IGR
  
• Quest Diagnostics and Genomic Vision Team Up to Develop Research and Clinical Testing Services
  
• EC Conditionally Approves Biogen Idec’s Multiple Sclerosis Drug Fampyra
  
• NeurOp Wins $3M from NIH to Progress NMDA Antagonist for Preventing Stroke
  
• Eye Movements in Mice Used to Evaluate CNS-Active Drug Efficacy, Receptor Interaction, Pharmacokinetics, and Toxicity
  
• Siena Biotech Selects Proteome Sciences as Preferred Biomarker Service Provider